Intracellular distribution and biological effects of phytochemicals in a sex steroid- sensitive model of human prostate adenocarcinoma

Anti-Cancer Agents in Medicinal Chemistry

Volumn 14, Issue 10, 2014, Pages 1386-1396

  Smeriglio, Antonella ^a,b   Trombetta, Domenico ^b   Marcoccia, Daniele ^a   Narciso, Laura ^a   Mantovani, Alberto ^a   Lorenzetti, Stefano ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Androgen receptor; Biomarker; Cytotoxicity; Flavonoids; Intracellular distribution; Nominal vs effective concentration; PSA secretion; Testing strategy

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; APIGENIN; BIOLOGICAL MARKER; ESTRADIOL; FLAVONOID; GENISTEIN; LUTEOLIN; NARINGENIN; PLANT MEDICINAL PRODUCT; POLYPHENOL DERIVATIVE; PROSTATE SPECIFIC ANTIGEN; QUERCETIN; RESVERATROL; SEX HORMONE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CELL; CELL FRACTIONATION; CELL PROLIFERATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DETERMINATION; DRUG DISTRIBUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MTS ASSAY; PHYTOCHEMISTRY; PROSTATE ADENOCARCINOMA; TUMOR MODEL; VALIDATION STUDY; ADENOCARCINOMA; CELL NUCLEUS; CELL SURVIVAL; DRUG EFFECTS; EPITHELIUM CELL; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; SECRETION (PROCESS); TUMOR CELL LINE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; EPITHELIAL CELLS; FLAVONOIDS; GONADAL STEROID HORMONES; HUMANS; MALE; PHYTOCHEMICALS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 84935516841     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/1871520614666140624111011     Document Type: Article

References (40)

1. Ross, J.A.; Kasum, C.M. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annu. Rev. Nutr., 2002, 22, 19-34.
2. Branca, F.; Lorenzetti S. Health effects of phytoestrogens. In: Forum Nutr., Diet diversification and health promotion; Elmadfa I Ed., Karger, Basel, 2005; Vol. 57, pp. 100-111.
3. Landete, J.M. Updated knowledge about polyphenols: Functions, bioavailability, metabolism, and health. Crit. Rev. Food Sci. Nutr., 2012, 52(10), 936-948.
4. Yao, L.H.; Jiang, Y.M.; Shi, J.; Tomas-Barberan, F.A.; Datta, N.; Singanusong, R.; Chen, S.S. Flavonoids in food and their health benefits. Plant Foods Hum. Nutr., 2004, 59(3), 113-122.
5. Surh, Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer, 2003, 3(10), 768-780.
6. Heiss, C.; Keen, C.L.; Kelm, M. Flavanols and cardiovascular disease prevention. Eur Heart J., 2010, 31(21), 2583-2592.
7. Kris-Etherton, P.M.; Lefevre, M.; Beecher, G.R.; Gross, M.D.; Keen, C.L.; Etherton, T.D. Bioactive compounds in nutrition and health-research methodologies for establishing biological function: The antioxidant and anti-inflammatory effects of flavonoids on atherosclerosis. Annu. Rev. Nutr., 2004, 24, 511-538.
8. Lorenzetti, S.; Branca, F. Phytoestrogens and the prevention of osteoporosis. In: Functional foods, ageing and degenerative disease; Remacle C. and Reusens B. Eds., Woodhead Publishing Ltd., Cambridge (UK); 2004, Food Science, Technology and Nutrition No. 82, pp. 115-138.
9. Weng, C.J.; Yen, G.C. Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo antimetastatic activities. Cancer Metastasis Rev., 2012, 31(1-2), 323-351.
10. Vauzour, D.; Rodriguez-Mateos, A.; Corona, G.; Oruna-Concha, M.J.; Spencer, J.P. Polyphenols and human health: Prevention of disease and mechanisms of action. Nutrients., 2010, 2(11), 1106-1131.
11. Romagnolo, D.F.; Selmin, O.I. Flavonoids and cancer prevention: A review of the evidence. J. Nutr. Gerontol. Geriatr., 2012, 31(3), 206-238.
12. Miller, P.E.; Snyder, D.C. Phytochemicals and cancer risk: A review of the epidemiological evidence. Nutr. Clin .Pract., 2012, 27(5), 599-612.
13. Nambiar, D.; Singh, R.P. Advances in prostate cancer chemoprevention: A translational perspective. Nutr. Cancer, 2013, 65(Suppl.1), 12-25.
14. Veveris-Lowe, T.L.; Kruger, S.J.; Walsh, T.; Gardiner, R.A.; Clements, J.A. Seminal fluid characterization for male fertility and prostate cancer: Kallikrein-related serine proteases and whole proteome approaches. Semin. Thromb Hemost., 2007, 33(1), 87-99.
15. Pampalakis, G.; Sotiropoulou, G. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer. Biochim. Biophys. Acta, 2007, 1776(1), 22-31.
16. Lorenzetti, S.; Narciso, L.; Marcoccia, D.; Altieri, I. 2012. A novel in vitro toxicological approach to identify chemicals with a prostate-mediated effect on male reproduction. J. Biol. Res., LXXXIV(1), 36-41.
17. Lorenzetti, S.; Altieri, I.; Arabi, S.; Balduzzi, D.; Bechi, N.; Cordelli, E.; Galli, C.; Ietta, F.; Modina, S.C.; Narciso, L.; Pacchierotti, F.; Villani, P.; Galli, A.; Lazzari, G.; Luciano, A.M.; Paulesu, L.; Spano, M.; Mantovani, A. Innovative non-animal testing strategies for reproductive toxicology: The contribution of Italian partners within the EU project ReProTect. Annals Ist Super Sanità, 2011, 47(4), 429-444.
18. Lorenzetti, S.; Marcoccia, D.; Narciso, L.; Mantovani, A. Cell viability and PSA secretion assays in LNCaP cells: A tiered in vitro approach to screen chemicals with a prostate-mediated effect on male reproduction within the ReProTect project. Reprod. Toxicol., 2010, 30(1), 25-35.
19. Gauthier, S.; Martel, C.; Labrie, F. Steroid derivatives as pure antagonists of the androgen receptor. J. Steroid. Biochem. Mol. Biol., 2012, 132(1-2), 93-104.
20. Marcoccia, D.; Georgiev, M.I., Alipieva, K., Lorenzetti, S. Inhibition of the DHT-induced PSA secretion by Verbascum xanthophoeniceum and Serenoa repens extracts in human LNCaP prostate epithelial cells. J. Ethnopharmacol., 2014.
21. Horoszewicz, J.S.; Leong, S.S.; Kawinski, E.; Karr, J.P.; Rosenthal, H.; Chu, T.M.; Mirand, E.A.; Murphy, G.P. LNCaP model of human prostatic carcinoma. Cancer Res., 1983, 43(4), 1809-1818.
22. Fizazi, K.; Navone, N.M. Preclinical models of prostate cancer. Bull. Cancer, 2005, 92(2), 129-141.
23. Wetherill, Y.B.; Fisher, N.L.; Staubach, A.; Danielsen, M.; De Vere White, R.W.; Knudsen, K.E. Xenoestrogen action in prostate cancer: Pleiotropic effects dependent on androgen receptor status. Cancer Res., 2005, 65(1), 54-65.
24. Caiozzi, G.; Wong, B.S.; Ricketts, M.L. Dietary modification of metabolic pathways via nuclear hormone receptors. Cell Biochem. Funct., 2012, 30(7), 531-551.
25. Lorand, T.; Vigh, E.; Garai, J. Hormonal action of plant derived and anthropogenic non-steroidal estrogenic compounds: Phytoestrogens and xenoestrogens. Curr. Med. Chem., 2010, 17(30), 3542-3574.
26. Lorenzetti, S.; Narciso, L. Nuclear receptors: Connecting human health to the environment. In: Computational approaches to nuclear receptors; Cozzini P. and Kellogg G.E. Eds., Royal Society of Chemistry Publishing, Cambridge (UK), 2012; RSC Drug Discovery series no. 30, pp. 1-22.
27. Rosenberg Zand, R.S.; Jenkins, D.J.; Brown, T.J.; Diamandis, E.P. Flavonoids can block PSA production by breast and prostate cancer cell lines. Clin. Chim. Acta., 2002, 317(1-2), 17-26.
28. Wang, P.; Heber, D.; Henning, S.M. Quercetin increased the antiproliferative activity of green tea polyphenol (-)-epigallocatechin gallate in prostate cancer cells. Nutr. Cancer, 2012, 64(4), 580-587.
29. Seo, Y.J.; Kim, B.S.; Chun, S.Y.; Park, Y.K.; Kang, K.S.; Kwon, T.G. Apoptotic effects of genistein, biochanin-A and apigenin on LNCaP and PC-3 cells by p21 through transcriptional inhibition of polo-like kinase-1. J. Korean Med. Sci., 2011, 26(11), 1489-1494.
30. Shukla, S.; Gupta, S. Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell Cycle, 2007, 6(9), 1102-1114.
31. Mitchell, S.H.; Zhu, W.; Young, C.Y. Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Cancer Res., 1999, 59(23), 5892-5895.
32. Umar, A.; Dunn, B.K.; Greenwald, P. Future directions in cancer prevention. Nat. Rev .Cancer, 2012, 12(12), 835-848.
33. Liu, A.; Pajkovic, N.; Pang, Y.; Zhu, D.; Calamini, B.; Mesecar, A.L.; Van Breemen, R.B. Absorption and subcellular localization of lycopene in human prostate cancer cells. Mol Cancer Ther., 2006, 5(11), 2879-85.
34. Mandalari, G.; Bennett, R.N.; Bisignano, G.; Saija, A.; Dugo, G.; Lo Curto, R.B.; Faulds, C.B.; Waldron, K.W. Characterization of flavonoids and pectins from bergamot (Citrus bergamia Risso) peel, a major byproduct of essential oil extraction. J. Agric .Food Chem., 2006, 54(1), 197-203.
35. Zhang, Z.; Duan, H.; Zhang, L.; Chen, X.; Liu, W.; Chen G. Direct determination of anabolic steroids in pig urine by a new SPME-GC-MS method. Talanta, 2009, 78(3), 1083-1089.
36. Zou, Y.; Li, Y.; Jin, H.; Tang, H.; Zou, D.; Liu, M.; Yang, Y. Determination of estrogens in human urine by high-performance liquid chromatography/diode array detection with ultrasound-assisted cloud-point extraction. Anal Biochem., 2012, 421(2), 378-384.
37. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use, ICH harmonised tripartite guideline, validation of analytical procedures: Text and Methodology Q2(R1). Complementary guideline on methodology dated Nov. 1996 incorporated in Nov. 2005. Available at: http://www.ich.org/fileadmin/Public_Web_Site/ ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1_Guideline. pdf.
38. Dai, J.; Shen, R.; Sumitomo, M.; Stahl, R.; Navarro, D.; Gershengorn, M.C.; Nanus, D.M. Synergistic activation of the androgen receptor by bombesin and low-dose androgen. Clin. Cancer Res., 2002, 8(7), 2399-2405.
39. Papadopoulou, N.; Papakonstanti, E.A.; Kallergi, G.; Alevizopoulos, K.; Stournaras, C. Membrane androgen receptor activation in prostate and breast tumor cells: Molecular signaling and clinical impact. IUBMB Life, 2009, 61(1), 56-61.
40. Castoria, G.; Lombardi, M.; Barone, M.V.; Bilancio, A.; Di Domenico, M.; Bottero, D.; Vitale, F.; Migliaccio, A.; Auricchio, F. Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J. Cell Biol., 2003, 161(3), 547-556.